Maria Bruzelius: Hemophilia and Bleeding Disorder in Clinical Practice at NordCoag 2026
Maria Bruzelius, President at NordCoag 2026, Associate Professor at Karolinska Institutet, shared NordCoag 2026‘s post on LinkedIn, adding:
”We continue to highlight our scientific programme at NordCoag 2026.
This session features our highly appreciated PedNet colleague, Christoph Königs together with psychologist Karl Björk – and it is seem that also I will be taking the stage… ”
NordCoag 2026 shared a post on LinkedIn:
”Session highlight of NordCoag 2026 Scientific Programme: Haemophilia in clinical practice
Haemophilia care is evolving, with new treatment options shaping clinical practice.
At this session, invited speaker Christoph Königs (Frankfurt, Germany) will speak on Experience with novel treatment options in haemophilia in Germany.
The session also includes speakers from Karolinska University Hospital with Maria Bruzelius on FVIII-Mimetic Treatment in Acquired Haemophilia A: Insights from the Karolinska Experience, and Karl Björk on Building psychological resilience in patients with chronic disease.
A session with perspectives on treatment, care and living with chronic disease. The full programme can be found on the NordCoag 2026 website, together with short bios of the speakers.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI